Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccinia Virus Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07398963
What this trial is testing

Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma

Who this might be right for
Refractory/Relapsed B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 48
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT01394939
What this trial is testing

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaCRC
Jennerex Biotherapeutics 52
Early research (Phase 1)Study completedNCT00574600
What this trial is testing

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Ended earlyNCT04725331
What this trial is testing

A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

Who this might be right for
Metastatic CancerSoft Tissue SarcomaMerkel Cell Carcinoma+3 more
Transgene 31
Not applicableStudy completedNCT00325975
What this trial is testing

Immune Responses to Smallpox Vaccination

Who this might be right for
Smallpox Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 69
Not applicableStudy completedNCT06650722
What this trial is testing

Evaluation of Healthcare Workers Knowledge Regarding Their Vaccination Status at Melun Hospital

Who this might be right for
Vaccinia
Groupe Hospitalier Sud Ile-de-France 100
Early research (Phase 1)Study completedNCT05976100
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years

Who this might be right for
SmallpoxMonkeypoxCowpox+1 more
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 90
Testing effectiveness (Phase 2)Ended earlyNCT03610581
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Who this might be right for
Human Papillomavirus Infections
Janssen Vaccines & Prevention B.V. 9
Early research (Phase 1)Study completedNCT00301184
What this trial is testing

Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)Looking for participantsNCT07190833
What this trial is testing

OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

Who this might be right for
Treatment-Refractory Solid Tumors
Bionoxx Inc. 27
Early research (Phase 1)WithdrawnNCT00006630
What this trial is testing

Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection

Who this might be right for
HealthyCommunicable Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00001056
What this trial is testing

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Very early researchActive Not RecruitingNCT06366672
What this trial is testing

Evaluating the Human Immune Response to the JYNNEOS Vaccine

Who this might be right for
VacciniaVirus Diseases
Washington University School of Medicine 20
Not applicableStudy completedNCT03745131
What this trial is testing

Cohort Study of Healthcare Workers Receiving Imvanex®

Who this might be right for
Monkeypox
Public Health England 120
Not applicableUnknownNCT05092568
What this trial is testing

Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service

Who this might be right for
Coronavirus Disease 2019VacciniaSymptoms and Signs
Saglik Bilimleri Universitesi 45
Early research (Phase 1)Study completedNCT03615911
What this trial is testing

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

Who this might be right for
MERS (Middle East Respiratory Syndrome)
Marylyn Addo 26
Large-scale testing (Phase 3)Ended earlyNCT02661464
What this trial is testing

Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 677
Testing effectiveness (Phase 2)Study completedNCT01636284
What this trial is testing

A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer

Who this might be right for
Hepatocellular Carinoma
Jennerex Biotherapeutics 16
Early research (Phase 1)Study completedNCT00189969
What this trial is testing

Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects

Who this might be right for
Smallpox
Bavarian Nordic 50
Next Page